Clinical Trials Logo

Clinical Trial Summary

Examination of the effect of Linagliptin versus placebo on diastolic function in patients with type 2 diabetes mellitus and diastolic dysfunction as assessed by transthoracic echocardiography.

Furthermore the effect on serum levels of NT-pro BNP as a biomarker of heart failure will be investigated.


Clinical Trial Description

Treatment:

The Patients will receive Linagliptin 5 mg QD or placebo for a period of 6 months.

The echocardiography and 24h RR measurement will be performed at baseline and 6 months after initiation of the therapy.

The blood chemistry (Glucose, HbA1c, BNP) will be evaluated at baseline as well as 3 and 6 months after initiation of the therapy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01888796
Study type Interventional
Source RWTH Aachen University
Contact
Status Terminated
Phase Phase 3
Start date September 2013
Completion date December 2014

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03962166 - Characterizing Patients With POAF in Relation to Cardiac Surgery by wavECG and TTE
Completed NCT04154878 - 2 New Measurements Used to Describe the Filling Phase of the Left Ventricle (LV).
Not yet recruiting NCT04549298 - Assessment of the Possible Association Between Left Ventricular Diastolic Dysfunction and Carotid Atherosclerosis and Brain White Matter Damage
Recruiting NCT01747187 - Cardiac Stress in Septic Shock - Biomarkers, Echocardiography and Outcome N/A
Completed NCT02251431 - Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome Phase 3
Completed NCT04699565 - Characterization of Patients With Post-ischemic Left Ventricular Dysfunction
Recruiting NCT04752293 - Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Completed NCT01961323 - Effect of Nebivolol on the Blood Flow in Hearts of Adults With High Blood Pressure and Abnormal Filling of Heart Phase 4
Completed NCT00405548 - Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function. Phase 1/Phase 2
Recruiting NCT04433533 - Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia Phase 4
Recruiting NCT03534037 - Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction Phase 4
Active, not recruiting NCT04687111 - Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation Phase 2
Completed NCT04505449 - Invasive Left Heart Catheterization Registry
Not yet recruiting NCT06431919 - Carvedilol + Simvastatin vs. Carvedilol Alone for Chronic Liver Disease and Cirrhotic Cardiomyopathy and Its Impact on Hepatic Decompensation and Survival; a Double-blind Randomized Controlled Trial N/A
Completed NCT04703387 - Left Ventricular Diastolic Dysfunction as a Predictor of Weaning Failure From Mechanical Ventilation
Terminated NCT03495999 - Hyperuricemia and Left Ventricular Diastolic Function
Completed NCT03522194 - Left Ventricular Diastolic Function During Anesthesia Induction